About UsOur CompaniesNewsManagement TeamBoard of DirectorsspacerCompliance Policy
News Header

Contacts:

Alyssa Schaier
Public Relations
(914) 589-6904

Patrick Aysseh, for
Informed Medical Communications
(646) 358-1304
pr_at_informedmedical-dot-com


For Immediate Release:

INFORMED MEDICAL COMMUNICATIONS NETWORK APPOINTS CARL D. BLANDINO CHIEF FINANCIAL OFFICER TO DRIVE GROWTH AND BOTTOM-LINE RESULTS

New York, NY - January 31, 2005 - Informed Medical Communications (IMC), an interactive medical marketing group of companies providing services to the biopharmaceutical industry, announced today the appointment of Carl D. Blandino as Chief Financial Officer. Based in IMC’s New York office and reporting directly to Chief Executive Officer, Robert Goodman, Mr. Blandino will oversee all financial operations and help drive growth of the company.
 
Mr. Blandino joins the IMC management team with 30 years of financial and operating experience at both private and public companies. Before joining IMC, he was Chief Financial Officer/Senior Vice President at Open Solutions Inc. (NASDAQ: Open – News), a provider of integrated data processing software. At Open Solutions, Mr. Blandino was instrumental in growing the company from $27 million in revenues to over $100 million in revenues in just three years. Mr. Blandino also has a strong background in mergers and acquisitions, initial public offerings and Sarbanes Oxley compliance. Mr. Blandino has also served as Chief Financial Officer at Online Resources & Communications Corp., Segue Software, Inc., Per-Se Technologies, and Health Innovations, Inc. Earlier in his career, he was a Senior Manager at Deloitte Haskins & Sells and a Manager at Coopers & Lybrand.
 
“Carl is a high-performance leader in a wide variety of financial responsibilities including organizational development, investor relations, strategic acquisitions, initial public offerings, accounting practices and financial forecasting,“ said Mr. Goodman. “His deep experience will be an instrumental asset as we continue to build our healthcare marketing business through acquisitions and organic growth,” added Mr. Goodman.
 
Over the last two years, IMC has grown by 117% from $23 million in Pro Forma revenues in 2003 to $50 million in revenues for 2005. IMC is a privately held network of companies that is backed by Ferrer Freeman & Company and Frazier Healthcare Ventures.
 
“Carl is a seasoned veteran in financial operations with a solid reputation in the financial community,” noted Alan Frazier of Frazier Healthcare Ventures. “His expertise will further enhance IMC’s successful track record as the company continues to grow and make significant strides in the pharmaceutical marketing arena.”
 
Mr. Blandino received his B.S. degree in finance and accounting from Robert Morris University and resides with his wife in Fairfield, Connecticut.
 
In addition to Mr. Blandino’s appointment, IMC has also engaged PricewaterhouseCoopers LLP as its independent auditor.
 
About Informed Medical Communications
Informed Medical Communications (www.informedmedical.com), headquartered in New York City, is an interactive medical marketing group of companies providing services to the biopharmaceutical industry. The companies include: The Peer Group, an industry innovator and leader in conducting peer-to-peer medical programs; HealthTalk, a pioneer in providing disease information and support resources that empower patients and caregivers coping with serious medical conditions to proactively and effectively manage their diseases; RxDialogue, a consumer relationship marketing company designed to give patients a deeper understanding of benefits and risks of treatment options in a highly personalized format not provided in traditional advertising; and MRxHealth, a market research and consulting firm that provides insights into the development and effectiveness of non-traditional marketing programs for physicians and patients. The IMC network of companies delivers integrated marketing programs for patients, physicians, medical professionals and payors, with the goal of improving the dialogue among patients and physicians in understanding health conditions and their medical options. IMC is a private-equity backed, privately held company.